Meningitis Vaccine – Healthy Infants
PMG Research of Bristol
42 – 89 days old at first study visit
A research study is evaluating an investigational quadrivalent meningococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants.
This research study may be an option if your child:
• Was born at full term weighing 5.5 lbs. or more
• Has received their first hepatitis B vaccine at least 28 days before the first study visit
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you and your child.
Qualified participants will receive all study-related care and study vaccine or an FDA-approved vaccine at no cost.
Patient Commitment Duration
Approximately 16 months
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 5 clinic visits and 6 phone calls